Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.K.
Pharma
England is not attractive place for investment, Lilly CEO says
In an interview with the Financial Times, Eli Lilly CEO David Ricks has called England “probably the worst country in Europe” for drug pricing.
Kevin Dunleavy
Sep 24, 2025 10:52am
EuroAPI sheds UK facility as restructuring plan rolls on
Jul 1, 2025 10:49am
Pfizer urges UK cancer docs to hear LGBTIQ+ patients out
May 21, 2025 2:30pm
Pharma giants demand revamp of UK drug cost control policy
Mar 20, 2025 10:57am
Upperton expands footprint with new UK sterile production plant
Jan 30, 2025 10:27am
AstraZeneca pledges £650M in UK to expand manufacturing, R&D
Mar 6, 2024 11:38am
